Clinical Trial Update: Adjunctive Everolimus Treatment of Refractory Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on adjunctive everolimus for refractory epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: National Institute on Drug Dependence, China | Conditions: Epilepsy | Phase 2 | Status: UNKNOWN